000 | 01103 a2200349 4500 | ||
---|---|---|---|
005 | 20250512092847.0 | ||
264 | 0 | _c19681103 | |
008 | 196811s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(68)92489-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBeaconsfield, P | |
245 | 0 | 0 |
_aOral contraceptives and the vital organs. _h[electronic resource] |
260 |
_bLancet (London, England) _cOct 1968 |
||
300 |
_a832-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aContraceptives, Oral _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 |
_aNorethynodrel _xpharmacology |
650 | 0 | 4 | _aRats |
700 | 1 | _aAbrams, M E | |
700 | 1 | _aGinsburg, J | |
700 | 1 | _aRainsbury, R | |
773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 7572 _gp. 832-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(68)92489-6 _zAvailable from publisher's website |
999 |
_c4181033 _d4181033 |